BlackRock’s Oncorus, Inc. ONCR Stock Holding History

BlackRock’s Portfolio ONCR Stock Details ONCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-139,040	Closed	-$47.8K	–	5652
2023 Q1	$47.8K	Sell	139,040 -632	-0.5%	-$236	﹤0.01%	5129
2022 Q4	$35.4K	Sell	139,672 -132,692	-49%	-$75.5K	﹤0.01%	5291
2022 Q3	$231K	Sell	272,364 -6,376	-2%	-$8.18K	﹤0.01%	4943
2022 Q2	$352K	Sell	278,740 -1,051,796	-79%	-$1.43M	﹤0.01%	4876
2022 Q1	$2.37M	Sell	1,330,536 -23,473	-2%	-$65.8K	﹤0.01%	4319
2021 Q4	$7.13M	Buy	1,354,009 +248,560	+22%	+$1.92M	﹤0.01%	3843
2021 Q3	$10.3M	Sell	1,105,449 -1,769	-0.2%	-$20.2K	﹤0.01%	3657
2021 Q2	$15.3M	Buy	1,107,218 +744,200	+205%	+$11.5M	﹤0.01%	3451
2021 Q1	$5.05M	Buy	363,018 +35,297	+11%	+$731K	﹤0.01%	3937
2020 Q4	$10.6M	Buy	+327,721	New	+$7.59M	﹤0.01%	3325

Other funds holding ONCR

MAM

MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return

MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

YAL

Your Advocates Ltd Houston, Texas $350M AUM 21.03% 1-Year Est. Return

BlackRock's ONCR Position: Q2 2023 in Review

BlackRock sold out of Oncorus, Inc. (ONCR) in Q2 2023, closing a stake of 139,040 shares — an estimated $47.8K sold.

BlackRock first reported a position in ONCR in Q4 2020 and held it in 10 quarters. The position peaked at $15.3M in Q2 2021. 4 funds tracked by Wall St. Rank hold ONCR as of Q2 2023.

BlackRock reported no remaining Oncorus, Inc. position as of Q2 2023 after selling out during the quarter.
BlackRock sold 139,040 Oncorus, Inc. shares in Q2 2023, an estimated $47.8K.
BlackRock first reported a position in Oncorus, Inc. in Q4 2020 and held it in 10 quarters.
BlackRock's Oncorus, Inc. position peaked at $15.3M in Q2 2021.
4 funds tracked by Wall St. Rank held Oncorus, Inc. as of Q2 2023.

Based on BlackRock's 13F filing for Q2 2023, filed 11 Aug 2023.